1. Australia
  2. Health Care
  3. Biopharmaceutical Purification

Biopharmaceutical Purification

  • 3M School of Purification

    The latest Bioprocessing Education Program by 3M

    Watch Now

  • 3M Innovations in Biopharmaceutical Clarification and Purification

Close

  • All fields are required unless indicated optional

  • 3M takes your privacy seriously. 3M and its authorized third parties will use the information you provided in accordance with our Privacy Policy to send you communications which may include promotions, product information and service offers. Please be aware that this information may be stored on a server located in the U.S. If you do not consent to this use of your personal information, please do not use this system.

  • Submit




 

Our apologies...

An error has occurred while submitting. Please try again later...

Thank you!

Your form was submitted successfully

Please click below to access whitepaper Frost & Sullivan: Perspective on Continuous Processing: Trends, Drivers and Strategies https://multimedia.3m.com/mws/media/1675020O/fs-continuous-processing-pdf.pdf

Close

  • All fields are required unless indicated optional

  • 3M takes your privacy seriously. 3M and its authorized third parties will use the information you provided in accordance with our Privacy Policy to send you communications which may include promotions, product information and service offers. Please be aware that this information may be stored on a server located in the U.S. If you do not consent to this use of your personal information, please do not use this system.

  • Submit




 

Our apologies...

An error has occurred while submitting. Please try again later...

Thank you!

Your form was submitted successfully

Please click below to access whitepaper Frost & Sullivan: Perspective on Continuous Processing: Trends, Drivers and Strategies https://multimedia.3m.com/mws/media/1675030O/fs-cell-therapy-biomanufacturing-pdf.pdf

Close

  • All fields are required unless indicated optional

  • 3M takes your privacy seriously. 3M and its authorized third parties will use the information you provided in accordance with our Privacy Policy to send you communications which may include promotions, product information and service offers. Please be aware that this information may be stored on a server located in the U.S. If you do not consent to this use of your personal information, please do not use this system.

  • Submit




Our apologies...

An error has occurred while submitting. Please try again later...

Thank you! Your form was submitted successfully

Please click below to access whitepaper:

Frost & Sullivan: Commercialisation Strategies in Global Biosimilars Industry

Close

  • All fields are required unless indicated optional

  • 3M takes your privacy seriously. 3M and its authorized third parties will use the information you provided in accordance with our Privacy Policy to send you communications which may include promotions, product information and service offers. Please be aware that this information may be stored on a server located in the U.S. If you do not consent to this use of your personal information, please do not use this system.

  • Submit




Our apologies...

An error has occurred while submitting. Please try again later...

Thank you! Your form was submitted successfully

Please click below to access whitepaper:

Frost & Sullivan: Enabling Novel Bioprocessing Technologies Using the Interface of Materials Science Biotechnology

Close

  • All fields are required unless indicated optional

  • 3M takes your privacy seriously. 3M and its authorized third parties will use the information you provided in accordance with our Privacy Policy to send you communications which may include promotions, product information and service offers. Please be aware that this information may be stored on a server located in the U.S. If you do not consent to this use of your personal information, please do not use this system.

  • Submit




Our apologies...

An error has occurred while submitting. Please try again later...

Thank you! Your form was submitted successfully

Please click below to access whitepaper:

Frost & Sullivan: Transition to Next Gen Downstream Processing to Capitalise on Growth Opportunities in High-Value Low-Volume Biologics

Close

  • All fields are required unless indicated optional

  •  
  •  
  •  
  •  
  •  

  • 3M takes your privacy seriously. 3M and its authorized third parties will use the information you provided in accordance with our Privacy Policy to send you communications which may include promotions, product information and service offers. Please be aware that this information may be stored on a server located in the U.S. If you do not consent to this use of your personal information, please do not use this system.

  • Submit




Thank you. Your form was submitted successfully!

Please click below to access the whitepaper:

Frost & Sullivan: Perspective on Next Generation Harvest Techniques

Our Apologies.

An error has occurred while submitting. Please try again later.

Close

  • All fields are required unless indicated optional

  •  
  •  
  •  
  •  
  •  

  • 3M takes your privacy seriously. 3M and its authorized third parties will use the information you provided in accordance with our Privacy Policy to send you communications which may include promotions, product information and service offers. Please be aware that this information may be stored on a server located in the U.S. If you do not consent to this use of your personal information, please do not use this system.

  • Submit





Thank you. Your form was submitted successfully!

Please click below to access the whitepaper:

Frost & Sullivan: Key Trends Reshaping The Future of Bio-pharmaceutical Harvest and Clarification

Our Apologies.

An error has occurred while submitting. Please try again later.





Biopharmaceutical Innovation. Pure and Simple.

We understand there’s tremendous pressure to increase speed to clinicals and lower manufacturing costs. Like you, we’re scientists and engineers devoted to increasing the number and availability of life-saving pharmaceuticals. We’ll work with you to optimise your processes, applying our biopharma experience, material science, and proprietary technologies to help you develop highly effective purification solutions.

Biopharmaceutical Applications

  • Image of recombinant proteins
    Recombinant Proteins

    At 3M, we're advancing the recombinant protein industry by building better, more efficient biopharmaceutical manufacturing processes, developing solutions that allow process compression, and enhanced drug recovery that leads to improved process economics.

  • Woman using a syringe and a vial
    Vaccines

    Our products and solutions help design and develop manufacturing processes for recombinant proteins including mAbs, vaccines and therapeutic plasma proteins. These products are designed for impurity removal in harvest, clarification and downstream polishing which help maximise upstream and downstream purity, leading to overall process economics.

  • Graphic of plasma fractionation
    Plasma Fractionation

    3M has been servicing the plasma fractionation industry for more than 30 years. We offer a range of products including depth filters, chromatography products, and membrane products, all of which are supported by our validation services offerings.

  • Person using a tool in a lab to transfer liquid
    Chemical Pharmaceuticals
    3M offers a wide range of adsorptive depth filters and membrane products for application in the chemical pharmaceutical industry. These products may be used for a range of applications including catalyst removal and recovery, colour removal, particulate filtration, and fill-finish.

World of Chromatography

  • Scientists in lab coats inspecting fluid

     

  • What can you expect from the program?

    Chromatography is a universal technique within the downstream processing of biopharmaceuticals. Its versatility is linked to the ability to separate species based on various properties such as charge, hydrophobicity, or specific interactions (e.g. between antibody and antigen) based on the ligand used. But that is only half the story, the matrix on which the ligand is immobilised also plays an important role.

    The 3M School of Purification offers a variety of content and tools, available in a range of formats, to help you learn more about biopharmaceutical separation and purification. Delve into the world of chromatography with our Master Class webinar recordings, designed to encompass the topics most impacting chromatography in bioprocessing.

    Register Now

Explore Product Solutions

Close

Contact Us

  • All fields are required unless indicated optional

    • Filtration Application Data (optional)

  •  

  • 3M takes your privacy seriously. 3M and its authorized third parties will use the information you provided in accordance with our Privacy Policy to send you communications which may include promotions, product information and service offers. Please be aware that this information may be stored on a server located in the U.S. If you do not consent to this use of your personal information, please do not use this system.

  • Submit

Thank you for your enquiry.

A 3M representative will be in contact with you shortly or you can call us on 1300 345 837 (option 3).

Our Apologies...

An error has occurred while submitting. Please try again later...

Ready to streamline your biopharmaceutical manufacturing process?
Ask a 3M Expert

Get in touch with a 3M Expert for tailored recommendations to transform your filtration processes and resolve challenges. Experience it for yourself with a demonstration and trial data.

Efficient workflows. Excellent clarity.

3M™ Harvest RC Chromatographic Clarifier, BT500 is the latest addition to the 3M™ Harvest RC Chromatographic Clarifier portfolio. It’s a rapid harvesting solution that saves time and steps without the need for a centrifuge.

LEARN MORE

Industry News

Discover insights from industry leaders on the latest trends in bioprocessing. Learn about innovations for optimisation of continuous manufacturing, changes in manufacturing landscapes from biosimilars, and new emerging markets such as cell and gene therapies.

  • Thumbnail of Key Trends Reshaping the Future of Bio-pharmaceutical Harvest & Clarification Paper
    Frost & Sullivan: Key Trends Reshaping The Future of Bio-pharmaceutical Harvest and Clarification
    Download paper (PDF, 2.16 MB)
  • Thumbnail of A Frost & Sullivan Perspective on Next Generation Harvest Techniques Paper
    Frost & Sullivan: Perspective on Next Generation Harvest Techniques
    Download paper (PDF, 577.94 KB)
  • Thumbnail of Transition to Next Gen Downstream Processing to Capitalise on Growth Opportunities in High-Value Low-Volume Biologics Paper
    Frost & Sullivan: Transition to Next Gen Downstream Processing to Capitalise on Growth Opportunities in High-Value Low-Volume Biologics
    Download paper (PDF, 689.89 KB)
  • Thumbnail of Anion-Exchange Chromatographic Clarification: Bringing Simplification, Robustness, and Savings to MAb Purification Paper
    BioProcess Int'l: Anion-Exchange Chromatographic Clarification: Bringing Simplification, Robustness, and Savings to MAb Purification
    Link to paper
  • Enabling Novel Bioprocessing Technologies PDF
    Frost & Sullivan: Enabling Novel Bioprocessing Technologies Using the Interface of Materials Science Biotechnology
    Download paper (PDF, 1.14 MB)
  • Perspective on Continuous Processing PDF
    Frost & Sullivan: Perspective on Continuous Processing: Trends, Drivers and Strategies
    Download paper (PDF, 800.42 KB)
  • Cell Therapy Biomanufacturing PDF
    Frost & Sullivan: Cell Therapy Biomanufacturing: Trends and Perspectives
    Download paper (PDF, 581.04 KB)
  • Thumbnail of A Frost & Sullivan Perspective on Commercialisation Strategies in Global Biosimilars Industry Paper
    Frost & Sullivan: Commercialisation Strategies in Global Biosimilars Industry
    Download paper (PDF, 1.49 MB)

Industry Awards

  • Image of 2017 Frost & Sullivan Global Biologics Product Leadership Award
    3M™ Emphaze™ AEX Hybrid Purifier recognised as global product leader

    2017 Frost & Sullivan Global Biologics Product Leadership Award. With its next generation technology product, the 3M™ Emphaze™ AEX Hybrid Purifier, 3M demonstrates leadership in meeting specific customer needs.

  • Image of 2018 Minnesota Tekne Biotech/Pharmaceutical Award
    3M™ Emphaze™ AEX Hybrid Purifier recognised at MN Tekne Award

    2018 Minnesota Tekne Biotech/Pharmaceutical Award. MN Tekne Awards celebrate innovation and pioneering efforts in biotechnology or pharmaceuticals to provide game-changing advancement in the healthcare field.

    Learn more about MN Tekne Awards
Legal
|
Privacy
|
Terms & Conditions
|
Cookie Preferences
© 3M 2025. All Rights Reserved.
Follow Us
The brands listed above are trademarks of 3M.